2022

• Novasep Process Solutions continues independently in its legacy market
• Novasep and PharmaZell become one group

• Novasep sales its chromatography equipment division to Sartorius

2021

• Thermo Fisher Scientific acquires Henogen S.A., Novasep’s viral vector manufacturing business in Belgium
  

2020

• Partnership with AstraZeneca to produce COVID-19 vaccine

• Investment of €6.5 million to expand capacity and increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site, France

Learn more about our site of Chasse-sur-Rhône

2019

• Novasep opens Senefill, a unit dedicated to Fill & Finish aseptic commercial operations in Seneffe, Belgium 

2018

• Novasep opens a new Viral Vector Commercial Production Facility in Seneffe, Belgium (€27m investment)

2017

• Novasep opens €11M new antibody-drug conjugate (ADC) bioconjugation unit 

2015

• Novasep opens the world’s largest chromatography plant in the pharmaceutical industry to produce omega-3 fatty acids.

2014

• Opening of the Sales Office of Bangkok, in Thailand
• Move of Group Management Center from Pompey to Lyon, in the Gerland Biodistrict

Learn more about the Group Management Center in Lyon Gerland 

2013

• Opening of the Sales office of Bangalore, in India
• Appointment of Michel Spagnol as CEO, then he was appointed as Chairman of the Administrative Board in March 2014

Read the biography of Michel Spagnol

 2012

• Opening of the Asia Process Development and Engineering Center in Shanghai, China

Learn more about the site of Shanghai

2009

• Acquisition of HENOGEN: cGMP upstream and downstream bioproduction, specialized in virus production and viral vectors.

2008

• €9M investment in a large scale biocatalysis / purification workshop in CSR

2007 - 2008

• Scale-up of new chemical technologies : Ozonolysis, Cyclopropanation, Carbonylation, O2 oxidation 

Discover our full range of Hazardous Chemistry services for APIs

2007

• Acquisition of PHARMACHEM: expansion of API manufacturing in North America

2006

• Development of BioSC, continuous chromatography technology for biomolecules purification

2005

• Industrial diborane and diazomethane chemistry
• Acquisition of DNES Dynamit Nobel Leverkusen's site and Finorga (sites of Chasse-sur-Rhône and Mourenx) 

Leverkusen                                                                                  Mourenx

2004

• Creation of Novasep Asia 
• Acquisition of APPLEXION and ORELIS: World leadership in purification processes for agro-bio-industrial industries

2003

• Acquisition of SERIPHARM, located in Le Mans, France: Global manufacturing leader of Highly Potent APIs
• Development of a global synthesis and purification CMO offer

2001

• Opening of the Pompey site, in France

1998

• Creation of Novasep, Inc in the US: Local presence on world major pharmaceutical market

1996

• First industrial pharma separation on an industrial scale by continuous chromatography

1995

• Creation of Novasep by Roger-Marc Nicoud: Niche expertise in continuous purification technologies 

Read all our Press Releases 

Curious to know more about what we are currently working on?

Check out our media & events page!